The post Maple Finance to Tie Into Elwood Technologies’ Systems to Bring Institutional Credit Strategies On-Chain appeared on BitcoinEthereumNews.com. Crypto credit firm Maple Finance and Elwood Technologies are joining forces to make it easier for large financial institutions to enter digital asset credit markets. The companies announced Monday that Maple’s on-chain lending and asset management platform will link up with Elwood’s execution, portfolio management, and risk tools. Maple, founded in 2021, specializes in structured lending products and yield strategies built on public blockchains. Elwood, the trading company backed by hedge-fund manager Alan Howard, provides connectivity to global crypto exchanges, custodians and fund administrators, along with analytics and risk monitoring tools for institutional investors. The collaboration targets a key friction point for traditional players. Banks and asset managers looking to diversify into digital assets face fragmented infrastructure and operational hurdles. By combining Maple’s lending expertise with Elwood’s institutional trading and risk systems, the firms aim to create a framework that mirrors what professional investors expect in traditional markets. Sid Powell, Maple’s CEO, said the partnership will extend “institutional-grade” access to on-chain credit opportunities. Elwood CEO Chris Lawn added that credit markets are an essential piece of crypto’s evolution and need the same type of infrastructure as other asset classes. The move comes as demand for tokenized credit and fixed-income products grows. For example, Ripple and Credbull recently launched initiatives that bring U.S. Treasuries and private credit onto blockchain rails. Maple and Elwood’s tie-up underscores how service providers are trying to position themselves as gateways for institutional capital entering the decentralized economy. Source: https://www.coindesk.com/business/2025/09/29/maple-finance-to-tie-into-elwood-to-bring-institutional-credit-strategies-on-chainThe post Maple Finance to Tie Into Elwood Technologies’ Systems to Bring Institutional Credit Strategies On-Chain appeared on BitcoinEthereumNews.com. Crypto credit firm Maple Finance and Elwood Technologies are joining forces to make it easier for large financial institutions to enter digital asset credit markets. The companies announced Monday that Maple’s on-chain lending and asset management platform will link up with Elwood’s execution, portfolio management, and risk tools. Maple, founded in 2021, specializes in structured lending products and yield strategies built on public blockchains. Elwood, the trading company backed by hedge-fund manager Alan Howard, provides connectivity to global crypto exchanges, custodians and fund administrators, along with analytics and risk monitoring tools for institutional investors. The collaboration targets a key friction point for traditional players. Banks and asset managers looking to diversify into digital assets face fragmented infrastructure and operational hurdles. By combining Maple’s lending expertise with Elwood’s institutional trading and risk systems, the firms aim to create a framework that mirrors what professional investors expect in traditional markets. Sid Powell, Maple’s CEO, said the partnership will extend “institutional-grade” access to on-chain credit opportunities. Elwood CEO Chris Lawn added that credit markets are an essential piece of crypto’s evolution and need the same type of infrastructure as other asset classes. The move comes as demand for tokenized credit and fixed-income products grows. For example, Ripple and Credbull recently launched initiatives that bring U.S. Treasuries and private credit onto blockchain rails. Maple and Elwood’s tie-up underscores how service providers are trying to position themselves as gateways for institutional capital entering the decentralized economy. Source: https://www.coindesk.com/business/2025/09/29/maple-finance-to-tie-into-elwood-to-bring-institutional-credit-strategies-on-chain

Maple Finance to Tie Into Elwood Technologies’ Systems to Bring Institutional Credit Strategies On-Chain

Crypto credit firm Maple Finance and Elwood Technologies are joining forces to make it easier for large financial institutions to enter digital asset credit markets. The companies announced Monday that Maple’s on-chain lending and asset management platform will link up with Elwood’s execution, portfolio management, and risk tools.

Maple, founded in 2021, specializes in structured lending products and yield strategies built on public blockchains. Elwood, the trading company backed by hedge-fund manager Alan Howard, provides connectivity to global crypto exchanges, custodians and fund administrators, along with analytics and risk monitoring tools for institutional investors.

The collaboration targets a key friction point for traditional players. Banks and asset managers looking to diversify into digital assets face fragmented infrastructure and operational hurdles. By combining Maple’s lending expertise with Elwood’s institutional trading and risk systems, the firms aim to create a framework that mirrors what professional investors expect in traditional markets.

Sid Powell, Maple’s CEO, said the partnership will extend “institutional-grade” access to on-chain credit opportunities. Elwood CEO Chris Lawn added that credit markets are an essential piece of crypto’s evolution and need the same type of infrastructure as other asset classes.

The move comes as demand for tokenized credit and fixed-income products grows. For example, Ripple and Credbull recently launched initiatives that bring U.S. Treasuries and private credit onto blockchain rails. Maple and Elwood’s tie-up underscores how service providers are trying to position themselves as gateways for institutional capital entering the decentralized economy.

Source: https://www.coindesk.com/business/2025/09/29/maple-finance-to-tie-into-elwood-to-bring-institutional-credit-strategies-on-chain

Market Opportunity
Chainlink Logo
Chainlink Price(LINK)
$8.555
$8.555$8.555
-2.34%
USD
Chainlink (LINK) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26